Inventor · disambiguated record
Mason Lu
Also filed as: LU MASON
12 granted patents·5 pending applications·137 citations·filing 2004–2024
92Inventor score
Top patents by PatentIndex Score
17 records- 0196US8088618B2Anti-IL 13 antibodies and uses thereofFUNG SEK CHUNG·Filed 2008·Granted Jan 3, 2012·41 cites·37 claims
- 0294US9605065B2Anti-IL13 antibodies and uses thereofGENENTECH INC·Filed 2013·Granted Mar 28, 2017·17 cites·24 claims
- 0393US8067199B2Anti-IL13 antibodies and uses thereofFUNG SEK CHUNG·Filed 2004·Granted Nov 29, 2011·39 cites·50 claims
- 0492US10752703B2Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2019·Granted Aug 25, 2020·7 cites·28 claims
- 0591US8734801B2Anti-IL13 antibodies and uses thereofFUNG SEK CHUNG·Filed 2011·Granted May 27, 2014·10 cites·32 claims
- 0690US8734797B2Anti-IL13 antibodies and uses thereofFUNG SEK CHUNG·Filed 2011·Granted May 27, 2014·10 cites·21 claims
- 0788US9067994B2Anti-IL13 antibodies and uses thereofFUNG SEK CHUNG·Filed 2011·Granted Jun 30, 2015·6 cites·19 claims
- 0886US11434287B2Anti-IL13 antibodies and uses thereofGENENTECH INC·Filed 2019·Granted Sep 6, 2022·2 cites·12 claims
- 0985US10738131B2Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2018·Granted Aug 11, 2020·2 cites·45 claims
- 1083US11939396B2Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2020·Granted Mar 26, 2024·1 cites·33 claims
- 1182US2024368306A1Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 1269US11267898B2Anti-PODXL antibody MAI1738 and its use for cancer treatmentMEDABOME INC·Filed 2019·Granted Mar 8, 2022·2 cites·20 claims
- 1367US2018251538A1Novel anti-il13 antibodies and uses thereofGENENTECH INC·Filed 2017·Application pending·0 cites
- 1458US2016200805A1Complement Pathway Inhibitors Binding To C5 And C5a Without Preventing The Formation Of C5bGENENTECH INC·Filed 2016·Application pending·0 cites
- 1556US11939391B2Anti-TfR1 antibody MAb11-22.1 conjugates for cancer treatmentMEDABOME INC·Filed 2021·Granted Mar 26, 2024·0 cites·19 claims
- 1651US2023391886A1Compositions and methods for muc18 targetingUNIV TEXAS·Filed 2021·Application pending·0 cites
- 1747US2021340232A1Monoclonal antibodies against human dickkopf3 and uses thereofUNIV TEXAS·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mason Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →